A Randomized, Double-blind, Double-dummy, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Different Doses of Indacaterol in Adult Patients With Persistent Asthma, Using Salmeterol as an Active Control.

Trial Profile

A Randomized, Double-blind, Double-dummy, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Different Doses of Indacaterol in Adult Patients With Persistent Asthma, Using Salmeterol as an Active Control.

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Jul 2011

At a glance

  • Drugs Indacaterol; Salmeterol
  • Indications Asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Jul 2011 Last checked against ClinicalTrials.gov record.
    • 29 Jul 2010 Actual end date added to 1 Jul 2010 as reported by ClinicalTrials.gov.
    • 29 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top